President and CEO Doug Love outlined a series of anticipated clinical and regulatory milestones during the 25th Annual ...
DeFi leaders say that AI will arm both attackers and defenders, and widen the gap between projects that prioritize security ...
MedPage Today on MSN
Cemdisiran siRNA therapy demonstrates efficacy in myasthenia gravis
Investigational treatment improves outcomes without complete complement blockade ...
ADAPT OCULUS is the first study to evaluate a targeted treatment for ocular MG, demonstrating that VYVGART significantly improves disease ...
Short-chain perfluorinated and polyfluorinated alkyl compounds (PFAS) such as perfluorobutanoic acid (PFBA) are increasingly ...
The Nuclear Non-Proliferation Treaty of 1968 was not a club with an arbitrary velvet rope. It was a bargain. Five states that had tested devices before 1 January 1967 — the US, Soviet Union, UK, ...
Olverembatinib, an investigational multikinase inhibitor (approved in China for CML), inhibits Src-family kinases (e.g., Lyn, ...
Your home is a treasure chest of items that, with a little creativity, can find a new purpose in your backyard. Before you ...
Morning Overview on MSN
Study tests combo approach to boost Alzheimer’s drugs and cut side effects
In the mountains of northwestern Colombia, thousands of members of extended families carry a single genetic mutation that all ...
Issued claims further strengthen global intellectual property portfolio supporting immune cell modulation platform and expand strategic presence in a high-growth international market LA JOLLA, CA, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results